Susan Escudier VIEW CLINICAL PROFILE

Susan Escudier, MD

Associate Professor of Clinical Medicine, Academic Institute
Houston Methodist


VIEW CLINICAL PROFILE
Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Clinical Fellowship, University of Texas MD Anderson Cancer Center
Publications

Impact of Remote Symptom Monitoring With Electronic Patient-Reported Outcomes on Hospitalization, Survival, and Cost in Community Oncology Practice: The Texas Two-Step Study
Patt, DA, Patel, AM, Bhardwaj, A, Hudson, KE, Christman, A, Amondikar, N, Escudier, SM, Townsend, S, Books, H & Basch, E 2023, , JCO clinical cancer informatics, vol. 7, pp. e2300182. https://doi.org/10.1200/CCI.23.00182

Symptomatic cryofibrinogenemia following trauma
Chamberlain, PD, Huttenbach, Y & Escudier, S 2017, , Journal of Clinical Rheumatology, vol. 23, no. 8, pp. 449-450. https://doi.org/10.1097/RHU.0000000000000590

Cetuximab-associated elongation of the eyelashes: Case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors
Cohen, PR, Escudier, SM & Kurzrock, R 2011, , American Journal of Clinical Dermatology, vol. 12, no. 1, pp. 63-67. https://doi.org/10.2165/11531920-000000000-00000

Acute lymphoblastic leukemia following preleukemic syndromes in adults
Escudier, SM, Albitar, M, Robertson, LE, Andreeff, M, Pierce, S & Kantarjian, HM 1996, , Leukemia, vol. 10, no. 3, pp. 473-477.

Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid
Escudier, S, Kantarjian, HM & Estey, EH 1996, , Leukemia and Lymphoma, vol. 20, no. 5-6, pp. 435-439. https://doi.org/10.3109/10428199609052425

High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement
Younes, A, Jendiroba, D, Engel, H, Escudier, S, Katz, R, Rodriguez, MA, Hill, D, Cabanillas, F & Andreeff, M 1994, , Cancer Genetics and Cytogenetics, vol. 77, no. 1, pp. 39-44. https://doi.org/10.1016/0165-4608(94)90146-5

Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation
Przepiorka, D, Ippoliti, C, Koberda, J, Chan, KW, Khouri, IF, Fischer, HE, Huh, YO, Escudier, SM, Seong, D, Davis, M, Gajewski, J, Vriesendorp, HM & Champlin, RE 1994, , Transplantation, vol. 58, no. 7, pp. 858-860. https://doi.org/10.1097/00007890-199410000-00022

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor
Estey, E, Thall, P, Andreeff, M, Beran, M, Kantarjian, H, OBrien, S, Escudier, S, Robertson, LE, Koller, C, Kornblau, S, Pierce, S, Freireich, EJ, Deisseroth, A & Keating, M 1994, , Journal of Clinical Oncology, vol. 12, no. 4, pp. 671-678. https://doi.org/10.1200/JCO.1994.12.4.671

Hematologic malignancies and pregnancy
Escudier, S & Keating, MJ 1994, , Cancer Bulletin, vol. 46, no. 5, pp. 418-423.

Use of Retroviral Markers to Identify Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Transplantation in Indolent B Cell Neoplasms (Follicular Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (CLL) Patients)
Deisseroth, A, Kantarjian, H, Champlin, R, Cabanillas, F, Keating, M, Reading, C, Andersson, B, Claxton, D, Robertson, B, Escudier, S, Andreeff, M, O’brien, S, Kornblau, S, Ellerson, D, Hanania, E & Fu, S 1993, , Human Gene Therapy, vol. 4, no. 6, pp. 821-834. https://doi.org/10.1089/hum.1993.4.6-821

Preliminary Results of Treatment with Filgrastim for Relapse of Leukemia and Myelodysplasia after Allogeneic Bone Marrow Transplantation
Giralt, S, Escudier, S, Kantarjian, H, Deisseroth, A, Freireich, EJ, Andersson, BS, Obrien, S, Andreeff, M, Fisher, H, Cork, A, Hirsch-Ginsberg, C, Trujillo, J, Stass, S & Champlin, RE 1993, , New England Journal of Medicine, vol. 329, no. 11, pp. 757-761. https://doi.org/10.1056/NEJM199309093291103

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia
Escudier, SM, Pereira-Leahy, JM, Drach, JW, Weier, HU, Goodacre, AM, Cork, MA, Trujillo, JM, Keating, MJ & Andreeff, M 1993, , Blood, vol. 81, no. 10, pp. 2702-2707.

Treatment of myelodysplastic syndromes with AML-type chemotherapy
Estey, E, Pierce, S, Kantarjian, H, Obrien, S, Beran, M, Andreeff, M, Escudier, S, Koller, C, Kornblau, S, Robertson, L & Keating, M 1993, , Leukemia and Lymphoma, vol. 11, no. S2, pp. 59-63. https://doi.org/10.3109/10428199309064263

Acute leukemia complicating bone marrow hypoplasia in an adult with shwachman's syndrome
Seymour, JF & Escudier, SM 1993, , Leukemia and Lymphoma, vol. 12, no. 1-2, pp. 131-135. https://doi.org/10.3109/10428199309059581

Treatment of Newly-Diagnosed AML with idarubicin + ARA-C
Estey, E, Kantajian, H, OBrien, S, Feldman, E, Koller, C, Beran, M, Andreeff, M, Escudier, S, Kornblau, S & Keating, M 1992, , Leukemia and Lymphoma, vol. 7, no. SUPPL. 2, pp. 28A.

Treatment of Newly-Diagnosed AML with Idarubicin + ARA-C
Estey, E, Kantarjian, H, OBRIEN, S, Feldman, E, Roller, C, Beran, M, Andreeff, M, Escudier, S, Kornblau, S & Keating, M 1992, , Leukemia & Lymphoma, vol. 7, no. sup2, pp. 121. https://doi.org/10.3109/10428199209058686

Carcinoma-associated hemolytic uremic syndrome in patients with genitourinary malignancies
Escudier, SM & Amato, RJ 1991, , Cancer Bulletin, vol. 43, no. 4, pp. 362-365.

Pathologic findings in the hearts of patients with acquired immunodeficiency syndrome
Klima, M & Escudier, S 1991, , Texas Heart Institute Journal, vol. 18, no. 2, pp. 116-121.

VIEW FULL PUBLICATIONS